Literature DB >> 27122872

Differentiation of Enhanced Green Fluorescent Protein-Labeled Mouse Amniotic Fluid-Derived Stem Cells into Cardiomyocyte-Like Beating Cells.

Shao-Yu Peng1, Yu-Sheng Yang2, Chih-Jen Chou1, Kun-Yi Lin3, Shinn-Chih Wu1.   

Abstract

BACKGROUND: Amniotic fluid-derived stem cells (AFSCs) possess optimal differentiation potential and are a promising resource for cell therapy and tissue engineering. Mouse is a good model to be studied for pre-clinical research.
METHODS: In this study, we successfully established enhanced green fluorescent protein mouse-derived amniotic fluid stem cells (EGFP-mAFSCs) and investigated whether EGFP-mAFSCs possess the ability to differentiate into cardiomyocytes by in vitro culture. We evaluated stem-cell differentiation using immunofluorescence.
RESULTS: This study showed that EGFP-mAFSCs can give rise to spontaneously beating cardiomyocyte-like cells expressing the specific markers c-kit, myosin heavy chain, and cardiac troponin I.
CONCLUSIONS: We demonstrated that mAFSCs have the in vitro propensity to acquire a cardiomyogenic phenotype and to a certain extent cardiomyocytes; however the process efficiency which gives rise to cardiomyocyte-like cells remains quite low (2 out of 10 were found). KEY WORDS: Amniotic fluid; Cardiomyocytes; In vitro differentiation; Stem cells.

Entities:  

Year:  2015        PMID: 27122872      PMCID: PMC4805003          DOI: 10.6515/acs20141027a

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  34 in total

1.  Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes.

Authors:  Kristine G Gaustad; Andrew C Boquest; Brent E Anderson; A Martin Gerdes; Philippe Collas
Journal:  Biochem Biophys Res Commun       Date:  2004-02-06       Impact factor: 3.575

2.  Jagged1 protein enhances the differentiation of mesenchymal stem cells into cardiomyocytes.

Authors:  Houwei Li; Bo Yu; Yan Zhang; Zhenwei Pan; Wei Xu; Hulun Li
Journal:  Biochem Biophys Res Commun       Date:  2006-01-10       Impact factor: 3.575

3.  Preclinical regulatory validation of a 3-stage amniotic mesenchymal stem cell manufacturing protocol.

Authors:  Shaun A Steigman; Myriam Armant; Lucy Bayer-Zwirello; Grace S Kao; Leslie Silberstein; Jerome Ritz; Dario O Fauza
Journal:  J Pediatr Surg       Date:  2008-06       Impact factor: 2.545

4.  Human umbilical cord cells: a new cell source for cardiovascular tissue engineering.

Authors:  Alexander Kadner; Simon P Hoerstrup; Jay Tracy; Christian Breymann; Christine F Maurus; Serguei Melnitchouk; Gregor Kadner; Gregor Zund; Marko Turina
Journal:  Ann Thorac Surg       Date:  2002-10       Impact factor: 4.330

5.  Amniotic mesenchymal cells autotransplanted in a porcine model of cardiac ischemia do not differentiate to cardiogenic phenotypes.

Authors:  Saverio Sartore; Maddalena Lenzi; Annalisa Angelini; Angela Chiavegato; Lisa Gasparotto; Paolo De Coppi; Roberto Bianco; Gino Gerosa
Journal:  Eur J Cardiothorac Surg       Date:  2005-09-26       Impact factor: 4.191

6.  Cardiomyocyte differentiation of mouse and human embryonic stem cells.

Authors:  C Mummery; D Ward; C E van den Brink; S D Bird; P A Doevendans; T Opthof; A Brutel de la Riviere; L Tertoolen; M van der Heyden; M Pera
Journal:  J Anat       Date:  2002-03       Impact factor: 2.610

7.  Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes.

Authors:  Sunil Rangappa; Chen Fen; Eng Hin Lee; Ariff Bongso; Eugene Kwang Wei Sim; Eugene Kwang Sim Wei
Journal:  Ann Thorac Surg       Date:  2003-03       Impact factor: 4.330

8.  Stem cells derived from amniotic fluid: new potentials in regenerative medicine.

Authors:  Mara Cananzi; Anthony Atala; Paolo De Coppi
Journal:  Reprod Biomed Online       Date:  2009       Impact factor: 3.828

9.  Characterization of embryoid bodies of mouse embryonic stem cells formed under various culture conditions and estimation of differentiation status of such bodies.

Authors:  Mikiko Koike; Shujiro Sakaki; Yoshifumi Amano; Hiroshi Kurosawa
Journal:  J Biosci Bioeng       Date:  2007-10       Impact factor: 2.894

Review 10.  Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review.

Authors:  Enca Martin-Rendon; Susan J Brunskill; Chris J Hyde; Simon J Stanworth; Anthony Mathur; Suzanne M Watt
Journal:  Eur Heart J       Date:  2008-06-03       Impact factor: 29.983

View more
  3 in total

Review 1.  Amniotic fluid cells: current progress and emerging challenges in renal regeneration.

Authors:  Stefano Da Sacco; Laura Perin; Sargis Sedrakyan
Journal:  Pediatr Nephrol       Date:  2017-06-15       Impact factor: 3.714

2.  Predifferentiated amniotic fluid mesenchymal stem cells enhance lung alveolar epithelium regeneration and reverse elastase-induced pulmonary emphysema.

Authors:  Ying-Wei Lan; Jing-Chan Yang; Chih-Ching Yen; Tsung-Teng Huang; Ying-Cheng Chen; Hsiao-Ling Chen; Kowit-Yu Chong; Chuan-Mu Chen
Journal:  Stem Cell Res Ther       Date:  2019-06-13       Impact factor: 6.832

Review 3.  Amniotic Fluid Cells, Stem Cells, and p53: Can We Stereotype p53 Functions?

Authors:  Melissa Rodrigues; Christine Blattner; Liborio Stuppia
Journal:  Int J Mol Sci       Date:  2019-05-07       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.